STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 83 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 6.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $132,000 | -56.9% | 27,214 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $306,000 | +3.7% | 28,785 | +1.7% | 0.00% | 0.0% |
| Q3 2019 | $295,000 | -24.4% | 28,303 | +11.1% | 0.00% | -50.0% |
| Q2 2019 | $390,000 | +24.6% | 25,472 | +4.5% | 0.00% | +100.0% |
| Q1 2019 | $313,000 | +76.8% | 24,385 | +31.0% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -43.1% | 18,614 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $311,000 | +7.6% | 18,757 | +4.2% | 0.00% | 0.0% |
| Q2 2018 | $289,000 | +11.2% | 18,003 | +6.0% | 0.00% | 0.0% |
| Q1 2018 | $260,000 | +9.7% | 16,978 | +11.6% | 0.00% | 0.0% |
| Q4 2017 | $237,000 | +41.1% | 15,211 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $168,000 | +30.2% | 15,138 | +8.1% | 0.00% | – |
| Q2 2017 | $129,000 | +43.3% | 14,007 | +32.9% | 0.00% | – |
| Q1 2017 | $90,000 | -13.5% | 10,543 | +8.8% | 0.00% | – |
| Q4 2016 | $104,000 | -99.9% | 9,693 | -0.3% | 0.00% | – |
| Q3 2016 | $105,257,000 | +60.2% | 9,719 | +0.1% | 0.00% | – |
| Q2 2016 | $65,703,000 | +52.8% | 9,705 | +6.1% | 0.00% | – |
| Q1 2016 | $43,000,000 | -25.9% | 9,151 | 0.0% | 0.00% | – |
| Q4 2015 | $58,000,000 | +71504.9% | 9,151 | -0.2% | 0.00% | – |
| Q3 2015 | $81,000 | -99.9% | 9,167 | +0.1% | 0.00% | – |
| Q2 2015 | $107,778,000 | +2.5% | 9,157 | +26.1% | 0.00% | – |
| Q1 2015 | $105,110,000 | -15.2% | 7,264 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $123,924,000 | +31.7% | 7,264 | -3.8% | 0.00% | – |
| Q3 2014 | $94,098,000 | -15.1% | 7,552 | -0.1% | 0.00% | – |
| Q2 2014 | $110,861,000 | -22.6% | 7,557 | +7.4% | 0.00% | -100.0% |
| Q1 2014 | $143,274,000 | +14.6% | 7,037 | +10.3% | 0.00% | 0.0% |
| Q4 2013 | $125,048,000 | -57.1% | 6,380 | -0.8% | 0.00% | -50.0% |
| Q3 2013 | $291,307,000 | – | 6,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |